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Abstract
Background: Globally, 40 % of children under 14 years are regularly exposed to secondhand smoke (SHS), typically
in their homes. There is limited evidence of the effectiveness of interventions to reduce children’s SHS exposure,
and so the aim of this study was to test the feasibility and acceptability of a novel intervention to help parents and
carers (caregivers) to reduce their children’s exposure to SHS at home.
Methods: A novel multi-component intervention to support caregivers to reduce their children’s SHS exposure at
home was tested in a two-phase feasibility study. The 12-week intensive intervention delivered in the home
consisted of three components: behavioural support, nicotine replacement therapy (NRT) for temporary abstinence
and feedback on levels of SHS exposure in the form of children’s salivary cotinine (phase 1) or home air quality
(PM2.5) (phase 2). Participants were caregivers who smoked inside their homes and had at least one child under the
age of 5 years living with them the majority of the time. Mixed-methods were used to explore the acceptability
and feasibility of the intervention as well as processes, particularly around recruitment and retention, for an
exploratory efficacy trial.
Results: Twelve caregivers completed the study, all received personalised feedback on SHS exposure and
behavioural support to help them to make their homes smoke-free and the majority at least tried NRT. Saliva
cotinine results were variable in phase 1, and therefore, measures of PM2.5 were used for feedback in phase 2.
Behavioural support was well received with personalised feedback reported as being the key motivator for initiating
and maintaining behaviour change.
Conclusions: Recruiting disadvantaged caregivers was labour intensive, but once recruited, this novel intervention
was both feasible and acceptable in supporting caregivers to reduce their children’s exposure to SHS at home. It is
appropriate to test the efficacy of this novel intervention in an exploratory randomised controlled trial.
Trial registration: This is not applicable for the current study; however, a registered exploratory randomised
controlled trial linked to this manuscript is currently ongoing (ISRCTN81701383).
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Background
Globally, 40 % of children under 14 years are exposed to
secondhand smoke (SHS), and of the 600,000 annual
deaths linked to exposure, 28 % occur in children [1].
Children’s exposure to SHS takes place predominantly in
the home [2, 3] and is largely attributed to parental
smoking in the home [4, 5]. Whilst exposure in England
has declined recently [5], 39 % of children who live with
smokers are still regularly exposed to SHS at home [6].
Children’s exposure to SHS has been causally linked
with a number of childhood morbidities [7–10], and it
has been estimated to result in an additional 300,000 UK
general practice consultations and 9500 hospital admis-
sions annually [10].
The most effective way to reduce children’s SHS ex-
posure is for their caregivers (parents and other carers)
to quit smoking. However, when caregivers continue to
smoke, the next best option is for them to make their
homes smoke-free. A systematic review [11] of 57 inter-
ventions and a further meta-analysis [12] of 30 studies
aimed at reducing children’s exposure to SHS found
mixed evidence for effectiveness which was insufficient
to recommend any one particular intervention strategy.
There is a need for more high quality, robust studies
with objective validation of children’s SHS exposure. In-
terventions based on behaviour change theories and in-
volving intensive and sustained contact with smoking
caregivers are reported to show the most promise [13].
In addition, a recent smoke-free homes (SFH) interven-
tion study [14] has shown that providing personalised
feedback on children’s SHS exposure as part of a motiv-
ational interview may have an effect on improving home
air quality and thus reducing children’s exposure to SHS
in the home.
Using the Medical Research Council (MRC) frame-
work for complex interventions as a guide [15], we com-
bined the findings from our previous research which
explored ways to support families to initiate and main-
tain a SFH [16, 17] with current evidence on what may
be effective components of SFH interventions, for ex-
ample: intensive and sustained counselling constructed
around sound behaviour change theory which focusses
on changing participant attitudes and behaviours [13,
18–20] and developed a novel multi-component inter-
vention to help reduce children’s exposure to SHS in the
home. The intervention, which aims to support care-
givers to reduce children’s exposure to SHS in the
home, combines intensive behavioural support, perso-
nalised feedback on household SHS levels and the offer
of nicotine replacement therapy (NRT), licensed for
temporary abstinence, as a substitute for smoking in
the home. The aim of the study was to assess the feasi-
bility and acceptability of this novel intervention using
a phased, iterative approach, to refine the individual
components and their delivery in preparation for an ex-
ploratory controlled efficacy trial. The specific objec-
tives of this study were to (a) assess participant
recruitment and retention rates and (b) explore the ac-
ceptability and feasibility of the behavioural support,
nicotine replacement therapy, and personalised feed-
back components of the intervention.
Methods
Phase 1 procedure
Design, setting and recruitment
A two-phase process was employed with refinement of
intervention components as necessary between phases.
Phase 1 ran from September 2011 to February 2012. Par-
ticipants were recruited via Sure Start Children Centres
(CCs) in Nottingham City, England, which are free to
join and offer free or subsidised activities and support
for low-income parents with children under 5 years. We
chose to recruit via CCs as the smoking rates amongst
caregivers accessing CCs are high [17]. At the time of
the study, there were 16 CCs in Nottingham City; 11
of these gave us permission to recruit and we ran-
domly selected five to recruit from. The five CCs
which declined to participate in the research reported
that this was due to competing priorities with service
delivery or concerns that we would not see sufficient
families who met the study inclusion criteria. The in-
clusion criteria required that participants smoked in-
side their home, were the primary caregiver of at
least one child under the age of 5 years who lived
with them, were not pregnant or breastfeeding, had a
fixed address for the intervention duration, were not
currently trying to quit smoking, were over the age of
18 years, had good spoken English and gave written
informed consent to participate. At the end of the
study, participants who had completed the whole
study protocol were offered a £50 retail voucher to
compensate for time given to participation. Other
smoking adults living in the same house as the primary
caregiver and able to be present at appointments were also
invited to receive the intervention. Ethical permission was
gained from the University of Nottingham Medical School
Ethics Committee (ref: E/03/2011).
Intervention (see Fig. 1)
Caregivers received a 12-week home-based intervention
which aimed to support them to reduce their children’s
exposure to SHS in the home and comprised of:
– Four sessions of face-to-face behavioural support
(up to 60 min each) to promote changes to home
smoking behaviours based on the principles of
motivational interviewing, delivered in homes by a
specialist SFH advisor. The support included
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caregiver education on the dangers of SHS, dis-
cussion of smoking behaviour and smoking rules
in households, and identifying barriers to change
and working with participants to elicit strategies
to overcome barriers.
– Up to a 12-week supply of NRT to support tempor-
ary abstinence in the home (rather than cessation)
by caregivers/other household adults. A variety of
NRT products were offered, to permit matching to
participants’ requirements, including use of NRT
combinations. All were supplied at no cost to the
participants.
– Urine and saliva samples were collected at each
visit from an ‘index’ child (typically the youngest,
but the primary caregiver was given the choice)
and analysed for cotinine (a metabolite of nicotine,
reflecting SHS exposure). Feedback on saliva
cotinine was provided and explained at the
subsequent visit (post-collection), and results were
compared to levels expected from children with
no SHS exposure (0–0.2 ng/ml), from children
living with a smoker (6 ng/ml), and from the
average level of a non-smoking bar worker heavily
exposed to SHS (3 ng/ml) [21].
Data collection methods and analysis
Quantitative data
Demographic questionnaires Questionnaires were de-
veloped in-house and pilot tested with PPI representatives
due to the lack of availability of validated questionnaires
which covered each of the areas of interest within the evi-
dence base. The questionnaires collected data on demo-
graphics, participant and child health and well-being,
family and household home smoking behaviours, NRT
use, and quit attempts, as well as beliefs around smoking
in the home with children present. The questionnaires
were administered at baseline and weeks 4, 8, and 12.
Cotinine measurement and feedback Saliva samples
from the index child were obtained using a Salimetrics
Children’s Swab (Salimetrics Europe Ltd). The swabs
were placed between the child’s inner cheek and gum
until saturated. Urine samples were also collected from
the index child in phase 1 by either a clean catch
method (for children who were toilet trained) or via cot-
ton pads in nappies. All samples were stored in a freezer
at −20 °C before being transported at ambient
temperature to ABS Laboratories (Cambridge, UK) for
Fig. 1 Diagrammatic representation of the two phases of the feasibility study
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analysis of cotinine concentrations with a limit of detec-
tion of 0.1 ng/ml.
Quantitative analysis Data from the interviewer-
administered questionnaires were captured using SPSS
version 14, and descriptive statistics were calculated.
Raw cotinine data were inputted into Microsoft Excel,
and descriptive statistics were calculated. Means and
ranges were used to summarise continuous data that
were normally distributed, and medians and ranges if
data were skewed. Categorical data were summarised
using counts and percentages.
Qualitative data
Evaluation interviews Within 2 weeks of their final
intervention visit, the participants were invited to take
part in an evaluation interview with an independent
researcher (MB). A semi-structured interview guide
(see Additional file 1) explored participants’ views and
experiences of taking part in the study, their general expe-
riences of trying to create a SFH, views on each compo-
nent of the intervention and how the intervention could
be improved.
Qualitative analysis Interviews were digitally audio-
recorded and transcribed verbatim with each transcript
subsequently checked to ensure data quality. Transcripts
were analysed using thematic analysis [22]. AL and JP
independently reviewed each transcript, and the initial
ideas were noted that identified preliminary codes. These
codes were then grouped into potentially relevant
themes and discussed between the analysts, the inter-
viewer (MB) and with the wider research team. Further
analysis clarified the specific nature of each theme
leading to the development of names and working de-
scriptions (Table 1). Following the agreement of the
identified themes, extracts were taken from the tran-
scripts to illustrate each theme in order to reflect the ex-
periences of the participants.
Results phase 1
Recruitment and retention
Recruitment for phase 1 was carried out over 14 weeks
from 39 Sure Start CC sessions; 256 people were
approached to assess eligibility, and 19 (7 %) met the in-
clusion criteria, of whom eight (42 %) were recruited.
Only a small number of those caregivers who were
approached to participate in the study were eligible as
the majority reported being a non-smoker, and of those
who reported smoking, only a small number reported
smoking inside the house. Two participants were subse-
quently lost to follow-up (data not presented). Only one
additional smoking adult who lived in a study household
was recruited (data not presented). Semi-structured
evaluation interviews were undertaken with three of the
six participants. Caregivers who did not complete an
evaluation interview were either not available to partici-
pate within the 2-week window at the end of the inter-
vention or declined to take part.
Study population
Participant baseline characteristics are presented in Table 2.
Acceptability and feasibility of behavioural support
Behavioural support discussions lasted between 20 and
60 min and were built around personalised feedback in
the form of saliva cotinine. At 12 weeks, all caregivers
Table 1 Themes interpreted from the qualitative evaluation
interview data
Core theme Sub-themes
Acceptability and feasibility of
behavioural support
- Approach and characteristics of the
advisor
- Face-to-face vs. telephone support
- Sharing of knowledge
- Practical support
- Discussion of personalised
feedback results
Acceptability and feasibility of
nicotine replacement therapy
- NRT sample bags
- Flexibility to change NRT
- Advice on how to maximise
effectiveness of NRT for temporary
abstinence
- Side effects
- Using NRT to quit in future
Acceptability and feasibility of
personalised feedback
- Urine vs. salvia cotinine
- Sampling techniques
- Air monitor set-up/data collection
- Impact and interpretation of results
Length and structure of
intervention
- Duration of the intervention and
number of visits
- Intervention intensity
- Amount of information provided at
each visit
- Timing of visits within intervention
period
- Disengagement/withdrawal
towards the end of the intervention
Facilitators and barriers to
participation in the intervention
- Recruitment approach
- Desire to quit
- Impact of other adult smokers in
the household and wider social
network
- Inconvenience allowance
- Safeguarding of children
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self-reported that the behavioural support component
was very (n = 2) or extremely (n = 4) helpful in support-
ing them to make their home smoke-free. All six partici-
pants ranked behavioural support at the second most
effective and important component of the intervention
package. In the evaluation interviews, the participants
described the behavioural support they received from
the SFH advisors as being important with a non-
judgemental approach being valued; resulting in
them not feeling stigmatised for smoking in their
homes or pressured to change their behaviour
(Fig. 2a). Instead, the participants recalled that the
SFH advisor encouraged and supported them in cre-
ating a SFH. This support was particularly important
in the early stages or when participants experienced
difficulties maintaining changes for reasons such as
bad weather which acted as a barrier to going out-
side to smoke (Fig. 2b).
Acceptability and feasibility of nicotine replacement therapy
At baseline, all six caregivers stated that they planned to
take up the offer of NRT to support them to make their
home smoke-free. Between baseline and week 4, five partic-
ipants reported that they had taken up the offer of NRT
and reported using the product/s (all five were using the in-
halator). Between weeks 4 and 8, five participants reported
that they had taken up the offer of NRT and reported using
the product/s (one was using an inhalator, one was using
an inhalator and quick mist, one was using an inhalator
and patches, two were using patches). Between weeks 8
and 12, four participants took up the offer of NRT of which
three reported using the products (one was using an inhal-
ator, one was using an inhalator and quick mist, one was
using an inhalator and patches, and one was using patches).
The participants reported predominantly using NRT to
help with cravings for short period of time and for helping
them to cut down without planning to quit smoking. As
Table 2 Feasibility sample baseline demographic characteristics
Phase 1 (n = 6) Phase 2 (n = 6) Evaluation interviewees (n = 7)
Age (years)
Mean (range) 27 (23–31) 26 (21–34) 26 (21–34)
Ethnicity n (%):
White British 5 (83.3) 4 (66.7) 4 (57.1)
Black or Black British 1 (16.7) 1 (16.7) 2 (28.6)
Caribbean
Mixed-White Caribbean 0 (0) 1 (16.7) 1 (14.3 %)
Black Caribbean
Age left full-time education (years)
Median (range) 16 (14–25) 16a (14–18) 16b (14–19)
Highest level of qualification n (%):
None 2 (33) 1 (17) 2 (29)
GCSE’s or similar 2 (33) 4 (67) 2 (29)
A/AS levels or similar 1 (17) 1 (17) 3 (43)
Degree or similar 1 (17) 0 (0) 0 (0)
Number of children in household
Median (range) 2 (2–4) 1 (1–2) 2 (1–4)
Housing n (%):
Rented 3 (50) 4 (67) 4 (57)
Local authority 3 (50) 2 (33) 3 (43)
Employment n (%):
Homemaker/full-time parent 5 (83) 4 (67) 5 (71)
Full-time paid work 1 (17) 0 (0) 0 (0)
Full-time student 0 (0) 2 (33) 2 (29)
Cigarettes/day
Median (range) 16 (8–30) 7 (3–20) 10 (3–30)
The totals may be greater than 100 due to rounding
an = 4 due to two participants still in full-time education
bn = 5 due to two participants still in full-time education
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part of the interviews, some participants stated the NRT
was useful and added that they planned to use the products
to quit smoking in the future having had a positive experi-
ence using NRT for temporary abstinence (Fig. 3a). In con-
trast, other participants reported problems such as side
effects resulting in them not using the products (Fig. 3b).
Acceptability and feasibility of personalised feedback
A total of seven (of a possible 24) urine samples were
collected (data are not presented). The collection of
urine samples was problematic with some children un-
able to provide a sufficient sample volume during the
visit and this could be distressing for caregivers and their
child. All 24 saliva samples were successfully collected
and analysed. The average saliva cotinine for the six par-
ticipants at each time point is shown in Fig. 4. On
average, saliva 12 cotinine declined by 3.3 ng/ml (range
−25.8 to 18.8 ng/ml) between baseline and week 12. The
participants reported, as part of the interviews, that col-
lecting saliva from children was acceptable and non-
intrusive. However, although the collection of saliva for
cotinine analysis from young children was acceptable, the
results were variable, not consistent with corresponding
urine cotinine results, and often did not reflect the home
smoking behaviour changes self-reported by participants.
Receiving feedback on saliva cotinine was emotive for a
number of participants, with some reporting that high co-
tinine levels were distressing. However, such results ap-
peared to prompt several participants to make changes to
their home smoking behaviours (Fig. 5a, b).
Learning from phase 1: protocol review
A review of the study design, processes and results was
undertaken by the research team at the end of phase 1.
The review led to the intervention being slightly modified
for phase 2 to help further improve acceptability and feasi-
bility and continue to inform the development of an ex-
ploratory efficacy trial. The length of the intervention
remained 12 weeks; however, the timing of the visits
throughout the 12 weeks was changed (see Fig. 1), increas-
ing the frequency of the visits and helping to maximise
support in the early weeks. To further support caregivers
proactive telephone support from the SFH advisor was in-
troduced in the second and fifth weeks. We introduced
the opportunity to sample different types of NRT during
the second visit to help ensure that participants were
a
b
c
Fig. 2 Acceptability and feasibility of behavioural support
a
b
c
Fig. 3 Acceptability and feasibility of nicotine replacement therapy
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prescribed the most suitable product/s to support them to
make their home smoke-free between visits.
Urine sample collection was removed from the proto-
col for phase 2 given the lack of acceptability and feasi-
bility of this as an outcome measure. Although saliva
sample collection was feasible and acceptable, the vari-
ability in results led the research team to explore alter-
native personalised feedback options for phase 2. Saliva
samples were still collected at four time points (baseline
and weeks 3, 7 and 12), but the results were not fed back
to participants unless requested at the end of the inter-
vention period (12 weeks). Building on the findings from
the REFRESH study [14] which showed that it was feas-
ible and acceptable to use home air quality data (PM2.5)
in SFH interventions, personalised feedback was given to
participants using PM2.5. Home air quality data were
collected at three time points (weeks 1, 7 and 12). Data
were collected for 48 h prior to the intervention visit,
and findings were uploaded immediately (with the
exception of week 1 when data were collected at the previ-
ous baseline visit) at the end of this collection period to a
laptop during the home visit and personalised graphical
feedback on home air quality provided to caregivers using
Microsoft Excel (see Fig. 6 for an example) during the visit.
Methods
Phase 2 procedure
Design, setting and recruitment
Phase 2 ran between March and August 2012. The par-
ticipants were again recruited via CCs, and the inclusion
criteria remained the same other than we included care-
givers who stated that they were interested in quitting
smoking to maximise potential recruitment.
Phase 2 intervention (see Fig. 1)
Families received a 12-week home-based intervention
which aimed to support caregivers to reduce their children’s
exposure to SHS in the home and comprised of:
Fig. 4 Average saliva cotinine results
a
b
c
d
Fig. 5 Acceptability and feasibility of personalised feedback
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– Four sessions of face-to-face behavioural support (up to
60 min each) and two proactive telephone behaviour
support sessions (up to 20 min each) to promote
changes to home smoking behaviours based on the
principles of motivational interviewing, delivered by
a specialist SFH advisor. The support included
caregiver education on the dangers of SHS,
discussion of smoking behaviour and smoking
rules in households and identifying barriers to
change and working with participants to elicit
strategies to overcome barriers.
– Up to an 11-week supply of NRT to support tempor-
ary abstinence in the home (rather than cessation) by
caregivers/other household adults. The participants
were able to sample all available products during visit
two and via discussion with the SFH advisor made an
informed choice about product/s. All were supplied at
no cost to the participants.
– Graphical and verbal feedback on home air quality
(PM2.5) at three time points (weeks 1, 7 and 12).
Data collection methods and analysis
Quantitative data
Demographic questionnaires The same questionnaire
data were collected as in phase 1, although question-
naires were administered at slightly different time points
(baseline and weeks 3, 7 and 12).
Cotinine measurement and feedback All 18 saliva sam-
ples were successfully collected and analysed. The average
saliva cotinine for the six participants at each time point is
shown in Fig. 4. On average, saliva cotinine increased by
1.3 ng/ml (range −16.0 to 17.5 ng/ml) between baseline and
week 12. The same measurement procedures to collect sal-
iva samples as in phase 1 were used. Feedback, in the same
format as that in phase 1, was only given to caregivers if re-
quested at the end of the intervention period (12 weeks).
Air quality measurement and feedback The concentra-
tion of airborne particulate matter <2.5 μm (PM2.5) was mea-
sured in the main living area of each household using a
SidePak AM510 Personal Aerosol Monitor for up to 48 h at
baseline, week 7, and week 12 (feedback was given at weeks
1, 7, and 12, see Fig. 6 for an example). Analysis was based
on 24 h of sampling in order to compare results to the
World Health Organisation’s (WHO) indoor air quality
guidelines [23]. The first and last 10 min of the 24-h
sampling time were disregarded to reduce potential bias, as a
researcher was often present during these periods. Max-
imum, minimum, and average levels of PM2.5 were calcu-
lated, having applied a calibration factor of 0.3 to the raw
data (to account for the lower density of SHS aerosol com-
pared to the road test dust used to calibrate the device), and
the results were compared to previous levels for week 7 and
12 visits. The amount of time that PM2.5 levels exceeded the
WHO 24 h guideline of 25 μm/m3 [23] was also reported.
Quantitative analysis Data from the interviewer admin-
istered questionnaires were captured using SPSS version
14 and descriptive statistics calculated. Raw cotinine
data were inputted into Microsoft Excel and descriptive
statistics calculated. SidePak PM2.5 data were analysed in
Microsoft Excel and data were log transformed to nor-
malised distributions. The percentage changes in average
(μm/m3), maximum (μm/m3), and time (minutes) over
25 μm/m3 (WHO indoor 24-h guideline) between base-
line and week 12 in air quality were calculated.
Qualitative data
Evaluation interviews Interviews for phase 2 followed
the same procedures as for phase 1 with only a small
Fig. 6 An example of a home air quality (PM2.5) feedback graph
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change to the interview guide to explore the feasibility
and acceptability of home air quality measurements and
feedback.
Qualitative analysis The same methods as phase 1 were
used to thematically analyse the interview transcripts
from phase 2.
Results phase 2
Recruitment and retention
The second phase of recruitment took 9 weeks and 26
CC sessions; 197 people were approached to assess eligi-
bility and 11 (6 %) met the inclusion criteria, of whom
six (55 %) were recruited with none lost to follow-up.
Highlighting an improvement in the ability to recruit
and retain participants between phase 1 and phase 2.
Only a small number of those caregivers who were
approached to participate in the study were eligible as
the majority reported being a non-smoker and of those
who reported smoking, only a small number reported
smoking inside the house. The overall retention rate
across the two phases was 86 %. No additional smoking
adults living in the study households were recruited in
phase 2.
Semi-structured evaluation interviews were under-
taken with four of the six participants. The participants
who did not complete an evaluation interview were ei-
ther not available to participate within the 2-week win-
dow at the end of the intervention or declined to take
part.
Study population
The participant baseline characteristics are presented in
Table 2. Phase 1 and 2 participants were similar in age,
education, housing and employment status but showed a
difference in the number of cigarettes smoked per day.
Acceptability and feasibility of behavioural support
Behavioural support discussions lasted between 20 and
60 min and were built around personalised feedback in the
form of PM2.5. At 12 weeks, all caregivers self-reported
that the behavioural support component was very (n = 4) or
extremely (n = 2) helpful in supporting them to make their
home smoke-free. The six participants ranked the behav-
ioural support as the most (n = 1) and the second (n = 3) or
the third (n = 2) most effective and important component
of the intervention package. Compared to phase 1, behav-
ioural support appeared to be viewed as a slightly less
important component of the overall intervention, although
in the interviews the participants described similar, positive
experiences aligned with the results from phase 1. The
participants were also positive about the inclusion of
additional, proactive telephone support, which provided
further support around creating and maintaining a SFH
aligned with behavioural support delivered during the face-
to-face sessions and was important during the early stages
and served to reassure them that support was available and
that they were not alone (Fig. 2c).
Acceptability and feasibility of nicotine replacement therapy
At baseline, three caregivers said that they planned to
take up the offer of NRT, two were unsure and one was
contraindicated (due to breast feeding) and so was un-
able to accept the offer. Between baseline and week 3,
five participants had taken up the offer of NRT and re-
ported using the product/s (two were using quick mist
and lozenges; two were using a combination of inhalator,
lozenges and quick mist; and one was using the inhal-
ator and quick mist). Between weeks 3 and 7, five partic-
ipants reported that they had taken up the offer of NRT
and reported using the product/s (one was using loz-
enges, one was using gum, one was using lozenges and
quick mist, one was using quick mist, and one was using
an inhalator and lozenges). Between weeks 7 and 12, five
participants took up the offer of NRT and all five re-
ported using the product/s (one was using lozenges; one
was using gum; one was using a combination of an in-
halator, lozenges and quick mist; one was using quick
mist; and one was using an inhalator and lozenges). The
participants reported predominantly using NRT to help
with cravings for short period of time and for helping
them to cut down without planning to quit smoking.
Views on NRT were very similar to that of the participants
in phase 1 with a number of participants reporting more
significant side effects (Fig. 3c).
Acceptability and feasibility of personalised feedback
Cotinine All 18 saliva samples were successfully collected
and analysed. On average, saliva cotinine increased by
1.3 ng/ml (range −16.0 to 17.5 ng/ml) between baseline
and week 12. The participants reported, as part of the in-
terviews, that collecting saliva from children was accept-
able and non-intrusive in line with phase 1.
Home air quality Twenty-four-hour log-transformed
data showed that compared to baseline, week 12 read-
ings were on average 49 % less in average levels of
PM2.5, 74 % less in the maximum level recorded and
75 % less in the total time PM2.5 levels were over the
WHO 24 h recommended level of 25 μg/m3 [23]. At
week 12, four out of six participants ranked the persona-
lised feedback as the most effective and important com-
ponent of the intervention. Monitoring of home air
quality was generally feasible and accepted, with only a
minority of participants expressing concerns about the
noise made by the monitor. The participants felt that
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they were able to understand the results and they appre-
ciated the personal, visual and ‘real-time’ nature of the
graphical and numerical feedback. Similar to the saliva
cotinine feedback, at first, the air monitor results caused
some participants to express ‘shock’ at the levels of
PM2.5 detected in their home (Fig. 5c). The participants
remarked that smoking in a different room to where the
air quality monitor was positioned still had a negative
impact on the air quality readings and that it often took
several hours after smoking for the PM2.5 levels to fall
below the WHO 24 h safe average of 25 μm/m3 [23]. As
a result, the caregivers were motivated to create a SFH
and reduce the levels of PM2.5 that the air quality moni-
tor detected in the home throughout the study (Fig. 5d).
Discussion
This study has demonstrated that this novel intervention
was feasible and acceptable to disadvantaged families to help
them to reduce their children’s exposure to SHS at home.
Qualitative findings highlighted that personalised feed-
back of children’s levels of SHS appeared to motivate be-
havioural change and that home air quality feedback was
the more reliable and acceptable method for doing this.
All participants appreciated the behavioural support
component of the intervention with some showing par-
ticular appreciation for the non-judgemental manner in
which it was delivered. The literature suggests that in-
creasing the intensity of home-based interventions can
increase their effectiveness [13]. The intervention was
made more intensive in phase 2 by adding proactive
telephone support and increasing the frequency of home
visits in the earlier stages of the intervention. It is pos-
sible that the intensive nature of the intervention and
the regular, personalised behavioural support encouraged
strong relationships to be built and therefore contrib-
uted to the good retention of study participants. The
changes to the structure of the intervention for phase 2
were also made to try and aid the transition to inde-
pendence for participants by making visits less frequent
towards the end of the intervention attempting to en-
courage participants to maintain changes on their own.
All participants not contraindicated accepted the ini-
tial offer of NRT for temporary abstinence but some
expressed negative views mainly around the side effects,
such as taste, which have been reported in other studies
[16]. However, other participants suggested that they
may go on to use NRT for a quit attempt in the future,
possibly as a result of their positive experience of using
NRT to temporarily abstain from smoking in the home
and so it is important that NRT is included as part of
the intervention in an exploratory efficacy trial.
Providing feedback via children’s cotinine whilst ac-
ceptable and feasible (for saliva) proved to be problem-
atic. Results were variable, often not consistent with
corresponding urine cotinine results, and did not reflect
the home smoking behaviour changes self-reported by
the participants. Ultimately, this variability had a detri-
mental effect on caregivers’ motivations to maintain any
changes to home smoking behaviours. A further limita-
tion of cotinine feedback is that it does not relate exclu-
sively to SHS exposure in the index household as levels
can be impacted by SHS exposures from other environ-
ments (such as if the child spends considerable time in a
grandparent’s home where smoking was unrestricted).
This issue limits the effectiveness of saliva cotinine feed-
back as an outcome measure for SFH interventions and
as a motivator for sustainable behaviour change.
In an attempt to overcome the issues with cotinine, home
air quality data (PM2.5) were used to provide personalised
feedback in phase 2. The graphical presentation of results
was well received and understood, supporting findings from
previous research which shows that smoking caregivers are
able to understand complex data presented to them in this
manner and that this type of feedback is acceptable and
motivating to caregivers [14]. It appears that the use of lon-
gitudinal air quality data helped to motivate caregivers to
initiate and maintain changes to their home smoking be-
haviours. By providing feedback on three occasions over
the 12-week intervention period, the participants were able
to see the positive effects that their behavioural changes
had on home air quality. There were however some poten-
tial issues with using home air quality, for example, moni-
tors were placed in one specific location within a
household and we were therefore unable to accurately in-
dicate air quality levels in other areas of the house, al-
though this location was identified as the place where the
child spent the most amount of time during the day. It is
also possible that participating families could change their
smoking behaviour inside the house for the period of time
that the monitor was present [14] although the partici-
pants reported that they often forgot that the monitor was
there and so it is unlikely that this would have significantly
influence the results. Finally, it is important to highlight
that whilst we have used the term SHS exposure through-
out this manuscript, PM2.5 is a proxy measure of personal
exposure and an indirect measure of SHS that is not spe-
cific to cigarette smoking as results can be influenced by
any airborne particles <2.5 μm in size.
The findings from the current study help to build on
the results of the REFRESH intervention feasibility study
[14, 24], although REFRESH did not offer caregivers
NRT, only provided home air quality feedback on two oc-
casions (compared to three in the current study) and the
intervention period was significantly shorter (4 vs.
12 weeks). The REFRESH results showed a statistically
significant decrease in maximum PM2.5 between weeks 2
and 4 within the intervention group but no significant
difference between the intervention and comparator arm
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[14]. Since the evidence base suggests that intensive and
sustained contact is more likely to be successful in helping
smoking caregivers to make changes [13], we might
expect our intervention to be more effective. This is
supported by the feasibility data which showed an average
decrease of 49 % between baseline and week 12 in average
PM2.5 and a 74 % reduction in the maximum PM2.5.
Recruitment proved labour intensive with a total of 65
Sure Start Children’s Centre sessions being attended in
order to recruit 14 participants. Only a small minority
(7 %) of the caregivers approached met the inclusion
criteria during the initial recruitment discussion about
the study. This is lower than we had anticipated given
the relatively high smoking rates of caregivers accessing
CCs [17] and that 39 % of children living with smokers
in England are reportedly exposed to SHS at home [6].
However, it may reflect the nature of recruitment in CCs
(sometimes in a public environment where the discus-
sion could be overheard) and the potential stigma at-
tached to smoking in the home with young children.
The caregivers may therefore have been smoking at
home but not willing to share this information with the
CC staff and/or research team and thus would be
deemed ineligible. In addition, we know that rules about
smoking at home are often fluid and that whilst care-
givers may initially state that they always smoke outside,
it is only with further exploration of home smoking rules
that it becomes apparent that caregivers sometimes
smoke inside [17]. To try and overcome this in the
explanatory RCT, a number of additional recruitment
strategies will be employed (including, for example, via
health visitor mail shots, outreach services, advertising,
the local stop smoking SFHs service) and more care taken
to ensure that recruitment discussions are conducted
more privately where possible. Having said this, nearly half
of eligible participants took part in the study and 12 of the
14 participating families completed the intervention. This
suggests that a proportion of smoking caregivers are inter-
ested in making changes to their home smoking behav-
iours and that the home setting, length and delivery of the
intervention were acceptable to them.
Conclusions
Accessing disadvantaged smoking caregivers was labour in-
tensive but once recruited, the caregivers found this novel
intervention both feasible and acceptable in supporting them
to protect their children from SHS exposure at home. Non-
judgemental support and encouragement over time, supple-
mented with personalised home air quality feedback, are key
to motivating caregivers to initiate and maintain changes to
their home smoking behaviours. The intervention tested in
phase 2 of this feasibility study did not require further
changes following detailed evaluation and is now being tested
for efficacy and cost-effectiveness in an exploratory RCT.
Additional file
Additional file 1: Caregiver week 12 interview guide.
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